Association of Codon 72 Polymorphism in Exon 4 of the TP53 Gene in Benign and Malignant Breast Tumors in Senegal

Authors

  • Hijeux Minte Cheikh Mohamed Malainy Samb Department of Animal Biology, Faculty of Science and Technology (FST), Cheikh Anta Diop University of Dakar (UCAD), Dakar, Senegal and Laboratoire of Genomic, Cheikh Anta Diop University, Animal Biology, Dakar-Fann, Senegal
  • Anna Ndong Department of Animal Biology, Faculty of Science and Technology (FST), Cheikh Anta Diop University of Dakar (UCAD), Dakar, Senegal and Laboratoire of Genomic, Cheikh Anta Diop University, Animal Biology, Dakar-Fann, Senegal
  • Mbacké Sembene Department of Animal Biology, Faculty of Science and Technology (FST), Cheikh Anta Diop University of Dakar (UCAD), Dakar, Senegal and Laboratoire of Genomic, Cheikh Anta Diop University, Animal Biology, Dakar-Fann, Senegal

DOI:

https://doi.org/10.14738/aivp.1401.19802

Keywords:

Tumor, Benign, Malignant, Breast, TP53, Exon 4, codon 72, Senegal

Abstract

Background: The Arg72Pro (R72P) polymorphism of the TP53 tumor suppressor gene has been controversially associated with breast cancer risk, with significant variations depending on ethnic origin. Little data exists for West African populations. This study seeks to evaluate the distribution and association of the R72P polymorphism of exon 4 of the TP53 gene with benign and malignant breast tumors in the Senegalese population. Methodology: The study was conducted on 48 Senegalese women: 17 with breast cancer (malignant), 12 with benign tumors, and 19 healthy controls. The polymorphism was genotyped by PCR followed by restriction fragment analysis. Polymorphism and allelic diversity, as well as genetic differentiation parameters and correspondence factor analysis, were generated using Genetix software version 4.05.2 and Bayesian inference with STRUCTURE. Hardy-Weinberg equilibrium was tested using GenePop software version 4.3. Results: The analysis revealed a distinct allele distribution, with a predominant frequency of the C allele (Pro72) in controls (77.7%) and an increased frequency of the G allele (Arg72) in patients with tumors (25% malignant, 12.5% benign). Statistically, no significant association was found between genotypes and the risk of developing malignant or benign breast tumors. Hardy-Weinberg equilibrium tests showed a significant imbalance in the patient populations, unlike in the controls. Finally, population genetic analyses (low FST differentiation indices, negligible genetic distances, and genetic structure in two clusters) indicated high genetic homogeneity between the three groups for this specific locus. Conclusion: Although differences in allele frequency were observed, the R72P polymorphism of TP53 is not an independent and significant risk factor for breast cancer in this Senegalese cohort. The high genetic homogeneity observed suggests that this variant alone is probably not a key determinant of breast pathology in this population. These results highlight the importance of local studies and the need for broader research incorporating other genetic and environmental factors.

References

Hanahan D., Weinberg R.A., « The hallmarks of cancer », Cell, 2000, Jan 7, 100(1), p. 57-70, ainsi que leur actualisation in « Hallmarks of cancer: the next generation », Cell, 2011, March 4, 144(5), p. 646-74.

Ollivier-Bousquet, M. (2006). Introduction-Les cellules mammaires: du développement normal à la transformation tumorale. Journal de la société de Biologie, 200(2), 179-180.

de Cremoux, P., & Robert, J. (2012). Cell signaling and cancer: characterization of therapeutic targets. Pathology Biology, 60(4), 217-222.

Smeby, J., Sveen, A., Eilertsen, IA, Danielsen, SA, Hoff, AM, Eide, PW, ... & Lothe, RA (2019). Transcriptional and functional consequences of TP53 splicing mutations in colorectal cancer. Oncogenesis, 8 (6), 35.

Kim, H., & Kim, Y. M. (2018). Pan-cancer analysis of somatic mutations and transcriptomes reveals common functional gene clusters shared by multiple cancer types. Scientific reports, 8(1), 6041.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, RL, Torre, LA, & Jemal, A. (2018). Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424.

Foulley, J. L., & Ollivier, L. (2006). Estimating allelic richness and its diversity. Livestock Science, 101(1-3), 150-158.

De Meeûs TM. Introduction to the genetics of natural populations: Application to parasites and their vectors. Marseille, IRD Editions, Didactiques Collection, 335p.

Nei, M. (1973). The theory and estimation of genetic distance.

Nei M. Molecular Evolutionary Genetics. Columbia University Press. 1987; New York, 506p.

Nei, M. (1978). The theory of genetic distance and evolution of human races. Japanese Journal of Human Genetics, 23(4), 341-369.

Rousset F. GENEPOP: a complete re-implementation of the GENEPOP software for Windows and Linux. Molecular Ecology Resources. 2008; 8: 103-106. Scholar Publishing

Lenfant P. Heterozygosity and selective value: the case of the marine fish, Diplodus sargus (Linnaeus, 1758). Proceedings. Biologies. 2002; 325(3), 239-252.

Weir, B. S., & Cockerham, C. C. (1984). Estimating F-statistics for the analysis of population structure. evolution, 1358-1370.

Belkhir K, Borsa P, Chikhi L, Raufaste N, & Bonhomme F. GENETIX 4.05, Windows TM software for population genetics. Laboratory Genome, Populations, Interactions, CNRS UMR 5171, University of Montpellier II, Montpellier. 2004.

Nei, M. (1972). Genetic distance between populations. The American Naturalist, 106(949), 283-292.

Takezaki N, & Nei M. Inconsistency of the maximum parsimony method when the rate of nucleotide substitution is constant. Journal of molecular evolution. 1994; 39, 210-218.

Hoda, Anila, and Paolo Ajmone Marsan. "Genetic characterization of Albanian sheep breeds by microsatellite markers." Analysis of genetic variation in animals. 2012; 3-27.

Pritchard, J. K., Stephens, M., & Donnelly, P. (2000). Inference of population structure using multilocus genotype data. Genetics, 155(2), 945-959.

Evanno, G., Regnaut, S., & Goudet, J. (2005). Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Molecular ecology, 14(8), 2611-2620.

PUECHMAILLE, Sebastien J. The program structure does not reliably recover the correct population structure when sampling is uneven: subsampling and new estimators alleviate the problem. Molecular ecology resources, 2016, vol. 16, no 3, p. 608-627.

Lin, H. Y., Huang, C. H., Wu, W. J., Chang, L. C., & Lung, F. W. (2008). TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses. International journal of biomedical science : IJBS, 4(4), 248–254.

Siddique, M., & Sabapathy, K. (2006). Trp53-dependent DNA repair is affected by codon 72 polymorphism. Oncogene, 25 (25), 3489-3500.

Aubrey, B. J., Strasser, A., & Kelly, G. L. (2016). Tumor-Suppressor Functions of the TP53 Pathway. Cold Spring Harbor perspectives in medicine, 6(5), a026062.

Ma, Y., Yang, J., Liu, Z., Zhang, P., Yang, Z., Wang, Y., & Qin, H. (2011). No significant association between TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects. Breast Cancer Research and Treatment, 125 (1), 201-205.

Gonçalves, ML, Borja, SM, Cordeiro, JABL, Saddi, VA, Ayres, FM, Vilanova-Costa, CAST, & Silva, AMTC (2014). Association between TP53 codon 72 polymorphism and breast cancer risk: a metaanalysis. Springerplus, 3 (1), 749.

Diakite, B., Kassogue, Y., Dolo, G., Wang, J., Neuschler, E., Kassogue, O., Keita, M. L., Traore, C. B., Kamate, B., Dembele, E., Nadifi, S., Murphy, R. L., Doumbia, S., Hou, L., & Maiga, M. (2020). p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. BMC medical genetics, 21(1), 206.

Koten, J. W., Neijt, J. P., Zonnenberg, B. A., & Den Otter, W. (1993). The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis. Anticancer research, 13(4), 1179–1182.

Rousseau, F., & Laflamme, N. (2003). Human molecular genetics: from monogenic diseases to complex diseases. M/S: Medicine Sciences, 19(10), 950-954.

Dozo, B.-O. (2011). 3. Correspondence factor analysis. In Mesures de l’écrivain. Liège: Presses universitaires de Liège.

Downloads

Published

2026-01-11

How to Cite

Samb, H. M. C. M. M., Ndong, A., & Sembene, M. (2026). Association of Codon 72 Polymorphism in Exon 4 of the TP53 Gene in Benign and Malignant Breast Tumors in Senegal. European Journal of Applied Sciences, 14(01), 158–175. https://doi.org/10.14738/aivp.1401.19802